BETA ENDORPHINS - HOLISTIC THERAPEUTIC APPROACH TO CANCER.
Level 5 - mechanism / opinion, no new human data
Narrative review of mechanisms and literature without systematic review methodology
What was done
A narrative review of literature searched across PubMed and Google Scholar examining studies, reviews, clinical trials, and author research on the anticancer and therapeutic properties of beta-endorphins.
What was found
No quantitative data, clinical outcome statistics, or effect estimates were reported in the abstract. The authors describe beta-endorphin as a proopiomelanocortin-derived endogenous opioid peptide with analgesic, anti-inflammatory, immune-stimulatory, stress-reducing, and euphoric actions.
Why it matters
It discusses potential theoretical and mechanistic pathways through which endogenous opioid signaling might modulate immune function and cancer symptoms.
Limits
This is an unsystematic narrative overview providing no quantitative synthesis, methodology for study selection, or clinical efficacy data in the abstract.
Cited by
- partial Beta-endorphin is 20 times more potent than morphine.